These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 8105213

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
    Mourits MP, Prummel MF, Wiersinga WM, Koornneef L.
    Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
    Marcocci C, Bartalena L, Tanda ML, Manetti L, Dell'Unto E, Rocchi R, Barbesino G, Mazzi B, Bartolomei MP, Lepri P, Cartei F, Nardi M, Pinchera A.
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Orbital radiotherapy combined with high dose systemic glucocorticoids for Graves' ophthalmopathy is more effective than radiotherapy alone: results of a prospective randomized study.
    Marcocci C, Bartalena L, Bogazzi F, Bruno-Bossio G, Lepri A, Pinchera A.
    J Endocrinol Invest; 1991 Nov; 14(10):853-60. PubMed ID: 1802923
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Corticosteroids in Moderate-To-Severe Graves' Ophthalmopathy: Oral or Intravenous Therapy?
    Penta L, Muzi G, Cofini M, Leonardi A, Lanciotti L, Esposito S.
    Int J Environ Res Public Health; 2019 Jan 08; 16(1):. PubMed ID: 30626069
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J, Zarković M, Stojanović M, Pepenezić Z, Randjelović G, Gligorović M, Trbojević B, Drezgić M, Nesović M.
    Srp Arh Celok Lek; 2000 Jan 08; 128(5-6):179-83. PubMed ID: 11089418
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Combined orbital irradiation and systemic steroids compared with systemic steroids alone in the management of moderate-to-severe Graves' ophthalmopathy: a preliminary study.
    Ng CM, Yuen HK, Choi KL, Chan MK, Yuen KT, Ng YW, Tiu SC.
    Hong Kong Med J; 2005 Oct 08; 11(5):322-30. PubMed ID: 16219950
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioiodine therapy for hyperthyroidism.
    Bartalena L, Marcocci C, Bogazzi F, Panicucci M, Lepri A, Pinchera A.
    N Engl J Med; 1989 Nov 16; 321(20):1349-52. PubMed ID: 2811943
    [Abstract] [Full Text] [Related]

  • 17. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
    Marcocci C, Bartalena L, Panicucci M, Marconcini C, Cartei F, Cavallacci G, Laddaga M, Campobasso G, Baschieri L, Pinchera A.
    Clin Endocrinol (Oxf); 1987 Jul 16; 27(1):33-42. PubMed ID: 3308192
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
    Brauer VF, Scholz GH.
    Med Klin (Munich); 2004 Feb 15; 99(2):71-6. PubMed ID: 14963657
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.